Related Experiment Video
Updated: Feb 11, 2026

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
Published on: June 22, 2012
Introduction to a review series on emerging immunotherapies for hematologic diseases
Sophie Paczesny1,2, Steven Z Pavletic3, Catherine M Bollard4,1,5
1Department of Pediatrics and.
Abstract:
Immune therapies are fast becoming paradigm-changing treatment options for patients with hematologic cancers. The field has grown exponentially as it expands to nonmalignant blood diseases. This Perspective article introduces the review series describing some of the latest advances in this field and highlighting some of the current obstacles and new opportunities for the future. Specifically, the series provides in-depth discussion on a selection of emerging immunotherapies now available to patients for hematologic diseases, including cancer vaccines, chimeric antigen receptor T cells, and immunotherapies to regulate inflammation in nonmalignant blood disorders.
Related Concept Videos
Introduction Cardiac Emergencies
RLC Series Circuits: Introduction
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction
Chronic Kidney Disease I: Introduction

